Michael Böhm

1.8k total citations
18 papers, 1.3k citations indexed

About

Michael Böhm is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Böhm has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Michael Böhm's work include Blood Pressure and Hypertension Studies (3 papers), Aortic Disease and Treatment Approaches (2 papers) and Aortic aneurysm repair treatments (2 papers). Michael Böhm is often cited by papers focused on Blood Pressure and Hypertension Studies (3 papers), Aortic Disease and Treatment Approaches (2 papers) and Aortic aneurysm repair treatments (2 papers). Michael Böhm collaborates with scholars based in Germany, United States and United Kingdom. Michael Böhm's co-authors include Georg Nickenig, Sven Waßmann, Michel Komajda, Ulrich Laufs, Karl Swedberg, Luigi Tavazzi, Jean‐Claude Tardif, Jeffrey Borer, Eileen O’Meara and Ian Ford and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Michael Böhm

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Böhm Germany 10 608 248 221 203 180 18 1.3k
Michele Dalla Vestra Italy 15 344 0.6× 141 0.6× 205 0.9× 340 1.7× 269 1.5× 37 1.6k
Hiromichi Wakui Japan 26 816 1.3× 228 0.9× 278 1.3× 583 2.9× 470 2.6× 125 1.9k
Kengo Azushima Japan 21 503 0.8× 162 0.7× 226 1.0× 492 2.4× 390 2.2× 94 1.5k
M. Temmar France 17 998 1.6× 342 1.4× 162 0.7× 135 0.7× 136 0.8× 32 1.7k
G. Riegger Germany 21 579 1.0× 183 0.7× 271 1.2× 171 0.8× 250 1.4× 56 1.4k
William G. McMaster United States 12 374 0.6× 237 1.0× 312 1.4× 239 1.2× 337 1.9× 20 1.5k
Aaron Wong United Kingdom 11 316 0.5× 157 0.6× 241 1.1× 347 1.7× 427 2.4× 30 1.1k
Diederick E. Grobbee Netherlands 15 628 1.0× 81 0.3× 268 1.2× 278 1.4× 289 1.6× 17 1.5k
Alessandro Mengozzi Italy 17 454 0.7× 184 0.7× 177 0.8× 200 1.0× 199 1.1× 50 1.0k
Matthew Nayor United States 23 1.1k 1.7× 199 0.8× 200 0.9× 139 0.7× 343 1.9× 69 1.7k

Countries citing papers authored by Michael Böhm

Since Specialization
Citations

This map shows the geographic impact of Michael Böhm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Böhm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Böhm more than expected).

Fields of papers citing papers by Michael Böhm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Böhm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Böhm. The network helps show where Michael Böhm may publish in the future.

Co-authorship network of co-authors of Michael Böhm

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Böhm. A scholar is included among the top collaborators of Michael Böhm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Böhm. Michael Böhm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Guimarães, Pedro, Andreas Keller, Michael Böhm, et al.. (2024). Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure. Hypertension. 82(1). 46–56.
2.
Abdin, Amr, Chris Wilkinson, Suleman Aktaa, et al.. (2024). European Society of Cardiology Quality Indicators Update for the Care and Outcomes of Adults with Heart Failure. The Heart Failure Association of the ESC. European Journal of Heart Failure. 26(9). 1867–1875. 8 indexed citations
3.
Lammert, Frank, et al.. (2018). Rafキナーゼ阻害剤蛋白質は心筋酸化ストレスの増強条件下で心筋線維症を仲介する【JST・京大機械翻訳】. Basic Research in Cardiology. 113(6). 1–20. 1 indexed citations
4.
Böhm, Michael, Ana Cristina Perez Moreno, Pardeep S. Jhund, et al.. (2014). Relationship between Heart Rate and Mortality and Morbidity in the Irbesartan Patients with Heart Failure and Preserved Systolic Function Trial (I-Preserve). European Journal of Heart Failure. 16(7). 778–787. 79 indexed citations
5.
Mahfoud, Felix, Daniel J. Urban, Sebastian Ewen, et al.. (2013). Treating resistant hypertension: role of renal denervation. PubMed. 6. 119–119. 11 indexed citations
6.
Ewen, Sebastian, Felix Mahfoud, & Michael Böhm. (2013). First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B. EuroIntervention. 8(9). 1110–1110. 3 indexed citations
7.
Lavall, Daniel, Hans‐Joachim Schäfers, Michael Böhm, & Ulrich Laufs. (2012). Aneurysms of the Ascending Aorta. Deutsches Ärzteblatt international. 109(13). 227–33. 44 indexed citations
8.
Tardif, Jean‐Claude, Eileen O’Meara, Michel Komajda, et al.. (2011). Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. European Heart Journal. 32(20). 2507–2515. 227 indexed citations
9.
Sinning, Jan‐Malte, et al.. (2011). CIRCULATING CD31+/ANNEXIN V+ MICROPARTICLES CORRELATE WITH CARDIOVASCULAR OUTCOMES. Journal of the American College of Cardiology. 57(14). E1555–E1555. 5 indexed citations
10.
Werner, Christian, Thomas Widmann, Janine Pöss, et al.. (2009). Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall. Circulation. 120(24). 2438–2447. 275 indexed citations
11.
Gouni‐Berthold, Ioanna, Heiner K. Berthold, Christos S. Mantzoros, Michael Böhm, & Wilhelm Krone. (2008). Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes. Diabetes Care. 31(7). 1389–1391. 135 indexed citations
12.
Grube, Markus, Kathleen Köck, Stefan Oswald, et al.. (2006). Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clinical Pharmacology & Therapeutics. 80(6). 607–620. 185 indexed citations
13.
Waßmann, Sven, Thomas Czech, Martin van Eickels, et al.. (2004). Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout Mice. Circulation. 110(19). 3062–3067. 156 indexed citations
14.
Harst, Pim van der, Meint Volbeda, Adriaan A. Voors, et al.. (2004). Vascular Response to Angiotensin II Predicts Long-Term Prognosis in Patients Undergoing Coronary Artery Bypass Grafting. Hypertension. 44(6). 930–934. 15 indexed citations
15.
Fries, Ruedi & Michael Böhm. (2003). Deep venous thrombosis - treatment. DMW - Deutsche Medizinische Wochenschrift. 128(18). 999–1002. 1 indexed citations
16.
Fries, Ruedi & Michael Böhm. (2003). Deep venous thrombosis - case report. DMW - Deutsche Medizinische Wochenschrift. 128(18). 993–993. 1 indexed citations
17.
Waßmann, Sven, et al.. (2003). Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function. Circulation Research. 93(9). e98–103. 140 indexed citations
18.
Graninger, W., et al.. (1977). Clinical Evaluation of the Effect of Cefuroxime in Patients with Pyelonephritis and Osteomyelitis. Proceedings of the Royal Society of Medicine. 70(9_suppl). 148–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Dalla Vestra Breakdown of academic impact, for papers by Hiromichi Wakui Breakdown of academic impact, for papers by Kengo Azushima Breakdown of academic impact, for papers by M. Temmar Breakdown of academic impact, for papers by G. Riegger Breakdown of academic impact, for papers by William G. McMaster Breakdown of academic impact, for papers by Aaron Wong Breakdown of academic impact, for papers by Diederick E. Grobbee Breakdown of academic impact, for papers by Alessandro Mengozzi Breakdown of academic impact, for papers by Matthew Nayor
Rankless by CCL
2026